CB Insights
Technology Market Intelligence
Technology Market Intelligence
Actinobac Biomed is a biopharmaceutical company developing therapeutics for multiple indications, including blood cancers, autoimmune/inflammatory diseases, and HIV. Its drug candidates are based upon Leukothera (LtxA), a natural protein that targets...Show all
Company (Alive / Active)
Phone: 732-371-2694
15 Pelham Road
Kendall Park, 08824
New Jersey, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Actinobac Biomed | $5.1M | Jun 8, 2018 |
| Xanthus Pharmaceuticals | $63.8M | Jun 9, 2008 |
| Nurel Therapeutics | $0M | Nov 22, 2005 |
| See all 57 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Treatment and diagnosis of ocular disease | Jun 27, 2014 | Apr 24, 2018 | Patent |
| Treatment and diagnosis of inflammatory disorders and hiv | Mar 24, 2016 | Dec 26, 2017 | Patent |
| Methods to treat inflammation of the lung | Jun 19, 2015 | Aug 08, 2017 | Patent |
| Combination therapy with leukotoxin | Mar 16, 2012 | May 31, 2016 | Patent |
| Treatment and diagnosis of inflammatory disorders and hiv | Dec 06, 2017 | Application |
